Investor Presentation First Nine Months of 2023 slide image

Investor Presentation First Nine Months of 2023

122 Investor presentation First nine months of 2023 Obesity market share and market growth in EMEA 120% 100% 80% 60% 40% 20% 0% Obesity market growth and Novo Nordisk market share Aug 2020 -NN market share -NN Growth -Market growth (right axis) DKK billion Obesity market size and growth ~71% 120% 3.5 0.0 88% 100% 88% 80% 2.1 71% 60% 40% 80% 20% 1.4 EMEA -88% 88% 0% Aug Aug Aug 2023 2022 2023 Novo Nordisk Others Source: IQVIA, Aug 2023, Value, MAT; EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; Market values are based on the list prices
View entire presentation